- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lixte Biotechnology Holdings Inc (LIXT)
Assess today's live Lixte Biotechnology Holdings Inc (LIXT) share price, performance and insights using our live NASDAQ: LIXT stock exchange data.
Analyse the historical data and Lixte Biotechnology Holdings Inc share price performance charts on this page. Our technical summary section provides analysis on Lixte Bio share price buy/sell indicators using real-time data (or discuss the Lixte Bio (LIXT) stock price today with other investors in the Lixte Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LIXT share price (ISIN: US5393193017) to enhance your trading decisions with our free investment tools and resources.
What Is the Lixte Biotechnology Holdings Inc Share Price Today?
The Lixte Bio share price today is 3.370.
What Is the Stock Symbol for Lixte Biotechnology Holdings Inc
The stock symbol (or 'ticker') for Lixte Biotechnology Holdings Inc is "LIXT."
What Stock Exchange Does Lixte Biotechnology Holdings Inc Trade On?
Lixte Biotechnology Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Lixte Biotechnology Holdings Inc a Good Stock to Buy?
Determining whether Lixte Biotechnology Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Lixte Biotechnology Holdings Inc share price performance charts on this page. Our technical summary section provides analysis on Lixte Bio share price buy/sell indicators using real-time data (or discuss the Lixte Bio (LIXT) stock price today with other investors in the Lixte Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LIXT share price (ISIN: US5393193017) to enhance your trading decisions with our free investment tools and resources.
What Is the Lixte Biotechnology Holdings Inc Share Price Today?
The Lixte Bio share price today is 3.370.
What Is the Stock Symbol for Lixte Biotechnology Holdings Inc
The stock symbol (or 'ticker') for Lixte Biotechnology Holdings Inc is "LIXT."
What Stock Exchange Does Lixte Biotechnology Holdings Inc Trade On?
Lixte Biotechnology Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Lixte Biotechnology Holdings Inc a Good Stock to Buy?
Determining whether Lixte Biotechnology Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.340
3.442
52 wk Range
0.640
6.260
LIXT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.3403.442
52 wk Range
0.6406.260
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIXT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
31/03/2026
EPS / Forecast
-0.32 / --
Revenue / Forecast
-- / --
Compare LIXT to Peers and Sector
Metrics to compare | LIXT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIXTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.4x | −3.6x | −0.5x | |
PEG Ratio | −0.30 | −0.09 | 0.00 | |
Price/Book | 4.9x | 2.6x | 2.6x | |
Price / LTM Sales | - | 32.3x | 3.2x | |
Upside (Analyst Target) | - | 164.7% | 47.8% | |
Fair Value Upside | Unlock | 2.6% | 6.7% | Unlock |
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company’s LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lixte Bio (NASDAQ: LIXT) Share Price Today?
The Lixte Bio stock price today is 3.370 USD.
What Stock Exchange Does Lixte Bio (LIXT) Trade On?
Lixte Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Lixte Bio?
The stock symbol (also called a 'ticker') for Lixte Bio is "LIXT."
What Is the Current Lixte Bio Market Capitalisation?
As of today, Lixte Bio (NASDAQ: LIXT) market cap is 39.150M USD.
What Is Lixte Bio's (LIXT) Earnings Per Share (TTM)?
The Lixte Bio EPS is currently -1.256 (Trailing Twelve Months).
Is LIXT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Lixte Bio moving averages and other technical indicators, the daily buy/sell signal for LIXT stock is Sell.
How Many Times Has Lixte Bio Stock Split?
Lixte Bio has split 2 times. (See the LIXT stock split history page for full effective split date and price information.)
How Many Employees Does Lixte Bio Have?
Lixte Bio has 3 employees, based on their latest Companies House report.
What is the current trading status of Lixte Bio (NASDAQ: LIXT)?
As of 02/05/2026, Lixte Bio (LIXT) is trading at a share price of 3.370 USD, with a previous close of 3.500 USD. The stock has fluctuated within a day range of 3.340 USD to 3.442 USD, while its 52-week range spans from 0.640 USD to 6.260 USD.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.